A. Eliot Shearer, MD, PhD
Otolaryngologist, Department of Otolaryngology and Communication Enhancement
Assistant Professor of Otolaryngology Head and Neck Surgery, Harvard Medical School
Image
A. Eliot Shearer, MD, PhD
Otolaryngologist, Department of Otolaryngology and Communication Enhancement
Assistant Professor of Otolaryngology Head and Neck Surgery, Harvard Medical School
Medical Services
Languages
English
Education
Undergraduate School
Ohio University Honors Tutorial College
2007
Athens
OH
Graduate School
University of Iowa College of Medicine
2014
Iowa City
IA
Medical School
University of Iowa College of Medicine
2014
Iowa City
IA
Internship
University of Iowa Hospitals & Clinics
2015
Iowa City
IA
Residency
University of Iowa Hospitals & Clinics
2019
Iowa City
IA
Fellowship
Boston Children's Hospital
2020
Boston
MA
Media
Parentcast Podcast
Dr. A. Eliot Shearer is featured: What do I do about my child’s ear infection?
Certifications
American Board of Otolaryngology (Head and Neck Surgery)
American Board of Otolaryngology (Complex Pediatric Otolaryngology)
Professional History
Dr. Eliot Shearer completed his MD, PhD, and residency training Otolaryngology — Head & Neck Surgery at the University of Iowa Hospitals & Clinics, considered one of the top training programs in the nation in Otolaryngology for more than 20 years. He then completed a fellowship in Pediatric Otolaryngology at Boston Children’s Hospital and Harvard Medical School. Dr. Shearer was invited to join the staff in the Department of Otolaryngology & Communication Enhancement at Boston Children’s Hospital following completion of his fellowship in 2020.
Dr. Shearer has experience and training in the entire breadth of Pediatric Otolaryngology. He has a special interest in the surgical management of pediatric ear disorders (otology) including hearing loss, ossicular abnormalities, cholesteatoma, bone anchored hearing aids, and cochlear implantation. Dr. Shearer is a member of the Cochlear Implant Program at Boston Children's Hospital.
Dr. Shearer is also a scientist. His laboratory studies the genetics of hearing loss and other ear, nose, and throat disorders. He is internationally recognized for his work in developing a new genetic testing platform for the diagnosis of hearing loss and has written many research articles and several book chapters on the subject. Dr. Shearer also studies ways to improve the newborn hearing screen using new technologies and ways to improve outcomes for children with cochlear implants.
Approach to Care
My goal is to treat every child as if they were my own. It is a huge responsibility to have parents trust me with care of their child and I am honored to be given the opportunity on a daily basis.
Publications
Correction: A proposal for comprehensive newborn hearing screening to improve identification of deaf and hard-of-hearing children. View Abstract
Massive Scalp Cylindromas Treated With Staged Resection and Split-Thickness Skin Grafting. View Abstract
Auditory synaptopathy, auditory neuropathy, and cochlear implantation. View Abstract
A proposal for comprehensive newborn hearing screening to improve identification of deaf and hard-of-hearing children. View Abstract
Adult type rhabdomyoma presenting as a parathyroid adenoma. View Abstract
In Vivo Electrocochleography in Hybrid Cochlear Implant Users Implicates TMPRSS3 in Spiral Ganglion Function. View Abstract
Genomic Landscape and Mutational Signatures of Deafness-Associated Genes. View Abstract
Comprehensive Genetic Testing for Deafness from Fresh and Archived Dried Blood Spots. View Abstract
Genetic variants in the peripheral auditory system significantly affect adult cochlear implant performance. View Abstract
Detection and Confirmation of Deafness-Causing Copy Number Variations in the STRC Gene by Massively Parallel Sequencing and Comparative Genomic Hybridization. View Abstract
Comprehensive genetic testing in the clinical evaluation of 1119 patients with hearing loss. View Abstract
Audioprofile Surfaces: The 21st Century Audiogram. View Abstract
Use of the Teres Major Muscle in Chimeric Subscapular System Free Flaps for Head and Neck Reconstruction. View Abstract
Sensorineural Hearing Loss: A Changing Paradigm for Its Evaluation. View Abstract
PRIMA1 mutation: a new cause of nocturnal frontal lobe epilepsy. View Abstract
Massively Parallel Sequencing for Genetic Diagnosis of Hearing Loss: The New Standard of Care. View Abstract
Mutation of the nuclear lamin gene LMNB2 in progressive myoclonus epilepsy with early ataxia. View Abstract
HOMER2, a stereociliary scaffolding protein, is essential for normal hearing in humans and mice. View Abstract
De novo mutation in X-linked hearing loss-associated POU3F4 in a sporadic case of congenital hearing loss. View Abstract
Hearing loss caused by a P2RX2 mutation identified in a MELAS family with a coexisting mitochondrial 3243AG mutation. View Abstract
Novel PTPRQ mutations identified in three congenital hearing loss patients with various types of hearing loss. View Abstract
USH2 caused by GPR98 mutation diagnosed by massively parallel sequencing in advance of the occurrence of visual symptoms. View Abstract
Challenges and solutions for gene identification in the presence of familial locus heterogeneity. View Abstract
Utilizing ethnic-specific differences in minor allele frequency to recategorize reported pathogenic deafness variants. View Abstract
Cordova: web-based management of genetic variation data. View Abstract
Copy number variants are a common cause of non-syndromic hearing loss. View Abstract
TBC1D24 mutation causes autosomal-dominant nonsyndromic hearing loss. View Abstract
An international effort towards developing standards for best practices in analysis, interpretation and reporting of clinical genome sequencing results in the CLARITY Challenge. View Abstract
Advancing genetic testing for deafness with genomic technology. View Abstract
AudioGene: predicting hearing loss genotypes from phenotypes to guide genetic screening. View Abstract
Genetics: advances in genetic testing for deafness. View Abstract
Pre-capture multiplexing improves efficiency and cost-effectiveness of targeted genomic enrichment. View Abstract
Prediction of cochlear implant performance by genetic mutation: the spiral ganglion hypothesis. View Abstract
Using the phenome and genome to improve genetic diagnosis for deafness. View Abstract
Screening for MYO15A gene mutations in autosomal recessive nonsyndromic, GJB2 negative Iranian deaf population. View Abstract
Solution-based targeted genomic enrichment for precious DNA samples. View Abstract
Deafness in the genomics era. View Abstract
Reducing the exome search space for mendelian diseases using genetic linkage analysis of exome genotypes. View Abstract
DFNA8/12 caused by TECTA mutations is the most identified subtype of nonsyndromic autosomal dominant hearing loss. View Abstract
Carcinoembryonic antigen-related cell adhesion molecule 16 interacts with alpha-tectorin and is mutated in autosomal dominant hearing loss (DFNA4). View Abstract
Loss-of-function mutations of ILDR1 cause autosomal-recessive hearing impairment DFNB42. View Abstract
Mutations in TMC1 are a common cause of DFNB7/11 hearing loss in the Iranian population. View Abstract
A novel mutation in COCH-implications for genotype-phenotype correlations in DFNA9 hearing loss. View Abstract
Comprehensive genetic testing for hereditary hearing loss using massively parallel sequencing. View Abstract
Frequency of Usher syndrome in two pediatric populations: Implications for genetic screening of deaf and hard of hearing children. View Abstract
Mutations in the first MyTH4 domain of MYO15A are a common cause of DFNB3 hearing loss. View Abstract
A novel splice site mutation in the RDX gene causes DFNB24 hearing loss in an Iranian family. View Abstract
Locations